These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 31926386)

  • 1. Evaluating hepatotoxic effects of chemotherapeutic agents with gadoxetic-acid-enhanced magnetic resonance imaging.
    Theilig D; Elkilany A; Jann H; Roderburg C; Hamm B; Fehrenbach U; Geisel D
    Eur J Radiol; 2020 Mar; 124():108807. PubMed ID: 31926386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consistency of hepatocellular gadoxetic acid uptake in serial MRI examinations for evaluation of liver function.
    Theilig D; Elkilany A; Schmelzle M; Müller T; Hamm B; Denecke T; Geisel D
    Abdom Radiol (NY); 2019 Aug; 44(8):2759-2768. PubMed ID: 31025071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatobiliary phase in cirrhotic patients with different Model for End-stage Liver Disease score: comparison of the performance of gadoxetic acid to gadobenate dimeglumine.
    Khouri Chalouhi C; Vernuccio F; Rini F; Duca P; Tuscano B; Brancatelli G; Vanzulli A
    Eur Radiol; 2019 Jun; 29(6):3090-3099. PubMed ID: 30547205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.
    Sun HY; Lee JM; Shin CI; Lee DH; Moon SK; Kim KW; Han JK; Choi BI
    Invest Radiol; 2010 Feb; 45(2):96-103. PubMed ID: 20057319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of the liver and pancreas in the hepatic arterial dominant phase: comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 Tesla MRI in the same patient.
    Kim HJ; Kim BS; Kim MJ; Kim SH; de Campos RO; Hernandes M; Semelka RC
    J Magn Reson Imaging; 2013 Apr; 37(4):903-8. PubMed ID: 23065959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic enhancement pattern of HCC smaller than 3 cm in diameter on gadoxetic acid-enhanced MRI: comparison with multiphasic MDCT.
    Park VY; Choi JY; Chung YE; Kim H; Park MS; Lim JS; Kim KW; Kim MJ
    Liver Int; 2014 Nov; 34(10):1593-602. PubMed ID: 24673802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visibility of focal liver lesions: Comparison between kupffer phase of CEUS with sonazoid and hepatobiliary phase of gadoxetic acid-enhanced MRI.
    Yang WY; Park HS; Kim YJ; Yu MH; Jung SI; Jeon HJ
    J Clin Ultrasound; 2017 Nov; 45(9):542-550. PubMed ID: 28547764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver imaging reporting and data system (LI-RADS) v2018: comparison between computed tomography and gadoxetic acid-enhanced magnetic resonance imaging.
    Nakao S; Tanabe M; Okada M; Furukawa M; Iida E; Miyoshi K; Matsunaga N; Ito K
    Jpn J Radiol; 2019 Sep; 37(9):651-659. PubMed ID: 31321619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting liver failure after extended right hepatectomy following right portal vein embolization with gadoxetic acid-enhanced MRI.
    Theilig D; Steffen I; Malinowski M; Stockmann M; Seehofer D; Pratschke J; Hamm B; Denecke T; Geisel D
    Eur Radiol; 2019 Nov; 29(11):5861-5872. PubMed ID: 30899977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gadoxetic acid-enhanced MRI of transient hepatic enhancement differences: Another cause of hypointense observation on hepatobiliary phase.
    Torrisi C; Picone D; Cabibbo G; Matranga D; Midiri M; Brancatelli G
    Eur J Radiol; 2018 Oct; 107():39-45. PubMed ID: 30292271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gadoxetic acid-enhanced MRI in primary sclerosing cholangitis: added value in assessing liver function and monitoring disease progression.
    Elkilany A; Geisel D; Müller T; Fischer A; Denecke T
    Abdom Radiol (NY); 2021 Mar; 46(3):979-991. PubMed ID: 32918576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined gadoxetic acid and gadofosveset enhanced liver MRI: A feasibility and parameter optimization study.
    Bannas P; Motosugi U; Hernando D; Rahimi MS; Holmes JH; Reeder SB
    Magn Reson Med; 2016 Jan; 75(1):318-28. PubMed ID: 25648403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the Functional Liver Imaging Score Derived from Gadoxetic Acid-enhanced MRI Predict Outcomes in Chronic Liver Disease?
    Bastati N; Beer L; Mandorfer M; Poetter-Lang S; Tamandl D; Bican Y; Elmer MC; Einspieler H; Semmler G; Simbrunner B; Weber M; Hodge JC; Vernuccio F; Sirlin C; Reiberger T; Ba-Ssalamah A
    Radiology; 2020 Jan; 294(1):98-107. PubMed ID: 31743083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A meta-analysis of diffusion-weighted and gadoxetic acid-enhanced MR imaging for the detection of liver metastases.
    Vilgrain V; Esvan M; Ronot M; Caumont-Prim A; Aubé C; Chatellier G
    Eur Radiol; 2016 Dec; 26(12):4595-4615. PubMed ID: 26883327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staging liver fibrosis in chronic hepatitis B with T
    Yang L; Ding Y; Rao S; Chen C; Wu L; Sheng R; Fu C; Zeng M
    J Magn Reson Imaging; 2017 Apr; 45(4):1186-1194. PubMed ID: 27563840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is MRI of the Liver Needed During Routine Preoperative Workup for Colorectal Cancer?
    Kang SI; Kim DW; Cho JY; Park J; Lee KH; Son IT; Oh HK; Kang SB
    Dis Colon Rectum; 2017 Sep; 60(9):936-944. PubMed ID: 28796732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Portal Hypertension on Gadoxetic Acid-Enhanced Liver Magnetic Resonance: Diagnostic and Prognostic Implications.
    Asenbaum U; Ba-Ssalamah A; Mandorfer M; Nolz R; Furtner J; Reiberger T; Ferlitsch A; Kaczirek K; Trauner M; Peck-Radosavljevic M; Wibmer AG
    Invest Radiol; 2017 Aug; 52(8):462-469. PubMed ID: 28622247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic Arterial Phase in Gadoxetic Acid-Enhanced Liver Magnetic Resonance Imaging: Analysis of Respiratory Patterns and Their Effect on Image Quality.
    Park YS; Lee CH; Yoo JL; Kim IS; Kiefer B; Woo ST; Kim KA; Park CM
    Invest Radiol; 2016 Feb; 51(2):127-33. PubMed ID: 26418367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MR-imaging features of hepatocellular carcinoma capsule appearance in cirrhotic liver: comparison of gadoxetic acid and gadobenate dimeglumine.
    Dioguardi Burgio M; Picone D; Cabibbo G; Midiri M; Lagalla R; Brancatelli G
    Abdom Radiol (NY); 2016 Aug; 41(8):1546-54. PubMed ID: 27052455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of Orthotopic Liver Transplant Graft Survival on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging Using Qualitative and Quantitative Parameters.
    Bastati N; Wibmer A; Tamandl D; Einspieler H; Hodge JC; Poetter-Lang S; Rockenschaub S; Berlakovich GA; Trauner M; Herold C; Ba-Ssalamah A
    Invest Radiol; 2016 Nov; 51(11):728-734. PubMed ID: 27175548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.